Pfizer CEO on Sales, M&A, mRNA, Weight Loss Drug

Pfizer CEO on Sales, M&A, mRNA, Weight Loss DrugПодробнее

Pfizer CEO on mRNA Vaccine Creation, R&D, Drug CostsПодробнее

Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors | At Barron'sПодробнее

Pfizer steps up race for weight-loss drugПодробнее

Efficacy of Pfizer's weight-loss drug 'inferior' to others on the market, says UBS's Colin BristowПодробнее

Pfizer CEO Bourla on Acuitas Deal, mRNA Tech, DjokovicПодробнее

Pfizer CEO windfall: Drug Company boss earns 5.6 millions from share saleПодробнее

Pfizer weight loss drug may be as effective as competitors: StudyПодробнее

Pfizer CEO explains why he hasn't received a vaccine yetПодробнее

FACT CHECK: Pfizer CEO Says Company Aims to Reduce World Population by Half by 2023?Подробнее

Covid will no longer be the epicenter of what we do, says Pfizer CEO Albert BourlaПодробнее

Pfizer vaccine risk detected, CDC saysПодробнее

Pfizer Buys Cancer-Drug Maker Seagen for $43 BillionПодробнее

Pfizer CEO on Sales, M&A, mRNA, Weight Loss DrugПодробнее

Expectations for Pfizer have been low, says Mizuho's Jared Holz on weight-loss pill setbackПодробнее

Pfizer stock rises on positive results from weight loss drug studyПодробнее

Thousands lining up for compensation, claiming the COVID vaccine made them sick | 7NEWSПодробнее

Pfizer's weight-loss pill won't be in direct competition with Ozempic, says BMO's Evan SeigermanПодробнее

Novak Djokovic breaks silence over Covid vaccine refusal - BBC NewsПодробнее

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effectsПодробнее